305 related articles for article (PubMed ID: 33208548)
1. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.
Shah S; Vazquez Do Campo R; Kumar N; McKeon A; Flanagan EP; Klein C; Pittock SJ; Dubey D
Neurology; 2021 Jan; 96(4):e632-e639. PubMed ID: 33208548
[TBL] [Abstract][Full Text] [Related]
2. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis.
Dubey D; Wilson MR; Clarkson B; Giannini C; Gandhi M; Cheville J; Lennon VA; Eggers S; Devine MF; Mandel-Brehm C; Kryzer T; Hinson SR; Khazaie K; Hales C; Kattah J; Pavelko KD; Andrews P; Eaton JE; Jitprapaikulsan J; Mills JR; Flanagan EP; Zekeridou A; Leibovich B; Fryer J; Torre M; Kaufman C; Thoreson JB; Sagen J; Linnoila JJ; DeRisi JL; Howe CL; McKeon A; Pittock SJ
JAMA Neurol; 2020 Nov; 77(11):1420-1429. PubMed ID: 32744608
[TBL] [Abstract][Full Text] [Related]
3. Multiplex serology of paraneoplastic antineuronal antibodies.
Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
Dubey D; Lennon VA; Gadoth A; Pittock SJ; Flanagan EP; Schmeling JE; McKeon A; Klein CJ
Neurology; 2018 Jan; 90(2):e103-e110. PubMed ID: 29222126
[TBL] [Abstract][Full Text] [Related]
5. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
6. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
7. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes.
Berger B; Stich O; Labeit S; Rauer S
J Neuroimmunol; 2016 Jun; 295-296():18-20. PubMed ID: 27235344
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
9. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
11. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
[TBL] [Abstract][Full Text] [Related]
12. Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.
Dubey D; Jitprapaikulsan J; Bi H; Do Campo RV; McKeon A; Pittock SJ; Engelstad JK; Mills JR; Klein CJ
Neurology; 2019 Nov; 93(20):e1873-e1880. PubMed ID: 31624089
[TBL] [Abstract][Full Text] [Related]
13. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic/autoimmune myelopathies.
Montalvo M; Flanagan EP
Handb Clin Neurol; 2024; 200():193-201. PubMed ID: 38494277
[TBL] [Abstract][Full Text] [Related]
15. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.
Pittock SJ; Kryzer TJ; Lennon VA
Ann Neurol; 2004 Nov; 56(5):715-9. PubMed ID: 15468074
[TBL] [Abstract][Full Text] [Related]
17. Neuro-ophthalmology and paraneoplastic syndromes.
Bataller L; Dalmau J
Curr Opin Neurol; 2004 Feb; 17(1):3-8. PubMed ID: 15090871
[TBL] [Abstract][Full Text] [Related]
18. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.
Déchelotte B; Muñiz-Castrillo S; Joubert B; Vogrig A; Picard G; Rogemond V; Pinto AL; Lombard C; Desestret V; Fabien N; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32170044
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.
Shelly S; Dubey D; Mills JR; Klein CJ
Handb Clin Neurol; 2024; 200():239-273. PubMed ID: 38494281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
